Axcella Health Inc. AXLA 0.00 Axcella Health Inc.

Home
  /  
Stock List  /  Axcella Health Inc.
Range:Vol Avg:0Last Div:0Changes:4.58
Beta:0.58Cap:0.00BCurrency:USDExchange:NASDAQ
Sector:HealthcareIPO:Thu May 09 2019Empoloyees:11
CUSIP:05454B105CIK:0001633070ISIN:US05454B2043Country:US
CEO:Mr. Craig R. Jalbert CIRAWebsite:https://www.axcellahealth.com
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence; and AXA1125 that is in Phase 2b clinical trial for treating non-alcoholic steatohepatitis, as well as in Phase 2a clinical trial for Long COVID therapy for patients. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.

Stock Details

The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
DMCA.com Protection StatusPowered by StackThrow